Global Efavirenz Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Efavirenz Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Efavirenz (EFV), sold under the brand names Sustiva among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals.
Efavirenz report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Efavirenz market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Adults and Children are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Efavirenz industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Efavirenz key manufacturers include Bristol-Myers Squibb, Teva, Mylan, Aurobindo Pharma, Cipla, Macleods Pharmaceuticals, Hetero, Strides Pharma and Gilead Sciences, etc. Bristol-Myers Squibb, Teva, Mylan are top 3 players and held % sales share in total in 2022.
Efavirenz can be divided into Single Efavirenz, Two-drug combination and Three-drug combination,, etc. Single Efavirenz is the mainstream product in the market, accounting for % sales share globally in 2022.
Efavirenz is widely used in various fields, such as Adults and Children, etc. Adults provides greatest supports to the Efavirenz industry development. In 2022, global % sales of Efavirenz went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Efavirenz market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bristol-Myers Squibb
Teva
Mylan
Aurobindo Pharma
Cipla
Macleods Pharmaceuticals
Hetero
Strides Pharma
Gilead Sciences
Segment by Type
Single Efavirenz
Two-drug combination
Three-drug combination
Adults
Children
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Efavirenz market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Efavirenz, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Efavirenz industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Efavirenz in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Efavirenz introduction, etc. Efavirenz Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Efavirenz market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Efavirenz report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Efavirenz market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Adults and Children are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Efavirenz industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Efavirenz key manufacturers include Bristol-Myers Squibb, Teva, Mylan, Aurobindo Pharma, Cipla, Macleods Pharmaceuticals, Hetero, Strides Pharma and Gilead Sciences, etc. Bristol-Myers Squibb, Teva, Mylan are top 3 players and held % sales share in total in 2022.
Efavirenz can be divided into Single Efavirenz, Two-drug combination and Three-drug combination,, etc. Single Efavirenz is the mainstream product in the market, accounting for % sales share globally in 2022.
Efavirenz is widely used in various fields, such as Adults and Children, etc. Adults provides greatest supports to the Efavirenz industry development. In 2022, global % sales of Efavirenz went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Efavirenz market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bristol-Myers Squibb
Teva
Mylan
Aurobindo Pharma
Cipla
Macleods Pharmaceuticals
Hetero
Strides Pharma
Gilead Sciences
Segment by Type
Single Efavirenz
Two-drug combination
Three-drug combination
Segment by Application
Adults
Children
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Efavirenz market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Efavirenz, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Efavirenz industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Efavirenz in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Efavirenz introduction, etc. Efavirenz Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Efavirenz market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices